Guidance for industry : amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"

Saved in:

Bibliographic Details
Imprint:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Description:	i, 4 pages : digital, PDF file
Language:	English
Subject:	Creutzfeldt-Jakob disease -- United States -- Prevention. Blood -- Transfusion -- Government policy -- United States. Blood products -- Government policy -- United States.
Format:	E-Resource U.S. Federal Government Document Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/7731625

Hidden Bibliographic Details
Varying Form of Title:	Amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products" Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vDJD) by blood and blood products
Other authors / contributors:	Center for Biologics Evaluation and Research (U.S.)
Notes:	Title from PDF title page (viewed on May 18, 2009). "Draft guidance." "August 2006". Includes bibliographical references (page 4). Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdfrance.pdf ; current access is available via PURL.
GPO item no.:	0499-T-02 (online)
Govt.docs classification:	HE 20.4802:D 71/3

Similar Items